MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Results for 8-week 48 mg Cohort in Phase 1b Trial of DA-1726 ...
As an adjunctive treatment, empagliflozin improves glycaemic control in patients with HNF1A-related maturity-onset diabetes ...
In a reminder of the money still on the table for enticing obesity assets, Corxel Pharmaceuticals has raised $287 million in ...
Clinicians who use the tool more often are less likely to order diagnostic tests and GDMT, even for HFrEF patients.
One of the persistent challenges in precision oncology is the fact that most advanced cancers are complex and highly individualized. A recent ...
Rapid weight loss can increase gallstone formation, and hospitalists have reported more cases of biliary colic and ...
Low-sodium oxybate reduces 24-hour sleep duration and daytime napping in adults with idiopathic hypersomnia, according to a phase 3 trial analysis.
When the NHS recognised ADHD in adults in 2008, never in my wildest hypochondriacal dreams did I imagine it applied to me. I ...
BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012DEE: 63.3% ...
Corxel Pharmaceuticals has raised $287m to fund its suite of cardiometabolic assets, signifying that investor appetite for ...
IPF-associated cough affects up to 80% of patients with IPF, substantially impairing their quality of life; consequently, ...
Let’s check what we’ve heard and what we think we know against the science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results